RB.L - Reckitt Benckiser Group plc

LSE - LSE Delayed Price. Currency in GBp
6,029.00
+29.00 (+0.48%)
At close: 4:38PM GMT
Stock chart is not supported by your current browser
Previous Close6,000.00
Open6,008.00
Bid5,860.00 x 20000
Ask6,060.00 x 3500
Day's Range5,966.00 - 6,040.00
52 Week Range5,255.00 - 7,174.00
Volume1,092,568
Avg. Volume1,460,986
Market Cap42.655B
Beta (3Y Monthly)1.12
PE Ratio (TTM)6.56
EPS (TTM)918.90
Earnings DateFeb 18, 2019
Forward Dividend & Yield1.41 (2.40%)
Ex-Dividend Date2018-08-16
1y Target Est7,085.56
  • The Wall Street Journal6 days ago

    [$$] Owner of Durex Condoms Is Looking for a New CEO

    LONDON—Reckitt Benckiser Group PLC’s chief executive, Rakesh Kapoor, will step down at the end of 2019 after eight years leading the owner of the Durex and Lysol brands. The consumer-goods company, whose other offerings include Air Wick fresheners and Dettol cleaning products, said Wednesday it has started its search for a successor and will consider both internal and external candidates. Mr. Kapoor, who has led the British company since 2011, is credited with pushing Reckitt deeper into higher-margin consumer-health products and away from slower-growing packaged food.

  • Reuters6 days ago

    Kenya hotel siege over, militants and at least 21 victims dead

    Kenyan security forces have killed all the Somali militants who stormed an upscale Nairobi hotel compound, taking at least 21 lives and forcing hundreds of people into terrifying escapes, the government said on Wednesday. Fifty people believed to have been in the complex remained unaccounted for on Wednesday afternoon, the Kenya Red Cross said, raising the possibility of a much higher final death toll. The bloody bodies of five attackers were broadcast across social media as President Uhuru Kenyatta announced the end of a 20-hour overnight siege that echoed a 2013 assault that killed 67 people in the Westgate shopping centre in the same district.

  • Reuters6 days ago

    Brexit deal defeat boosts European banks

    By Helen Reid LONDON (Reuters) - European shares closed the day in positive territory on Wednesday as British Prime Minister Theresa May's resounding defeat in a parliamentary vote on her Brexit deal gave ...

  • Reuters6 days ago

    Reckitt Benckiser CEO to retire after setbacks mar latter years

    The company behind Durex condoms and Enfamil infant formula said Kapoor, 60, would leave by the end of 2019 after more than eight years at the helm and more than three decades with the company overall. Reckitt has begun looking for a successor and will consider internal and external candidates. Indian-born Kapoor is the latest consumer industry chief to hand over the reins in difficult times, marked by slower growth, little pricing power and changing consumer habits.

  • The Wall Street Journal7 days ago

    [$$] Lysol's Owner Wants a New Cleaner

    ’s outgoing boss was everything investors could wish for in a consumer company executive. Shares in the owner of household brands like Scholl foot care, Durex condoms and Lysol disinfectant fell 3% Wednesday after the surprise announcement that the 60-year old CEO will retire by the end of 2019. During an eight-year tenure, Mr. Kapoor expanded into fast-growing developing markets like India and China, pushed into baby food with the $17 billion purchase of Mead Johnson in 2017 and delivered total shareholder returns of 130%.

  • Reckitt CEO Leaves With the Housework Half Done
    Bloomberg7 days ago

    Reckitt CEO Leaves With the Housework Half Done

    The highly paid Chief Executive Officer will step down by the end of 2019 after eight years in the role. The $16.6 billion deal stretched Reckitt's management too thin, leaving it vulnerable to the Petya cyber attack a few months later. Kapoor responded by reorganizing the company, dividing the health business, including Nurofen and Mead Johnson's infant formula, from the more mature but cash generative hygiene and home business, containing Vanish and AirWick.

  • Reckitt CEO to Leave After Eight Years Capped by Setbacks
    Bloomberg7 days ago

    Reckitt CEO to Leave After Eight Years Capped by Setbacks

    The maker of Lysol air fresheners and Nurofen painkillers did not name a successor to Kapoor, 60, but said it’s initiated a search that will consider internal and external candidates. The move comes after shareholders punished Reckitt Benckiser for a series of setbacks, cutting the stock price by about one-third from a 2015 peak. Until the problems cropped up, the company under Kapoor was one of the strongest performers in the packaged-goods industry, where owners of big brands have struggled as shoppers seek out fresh alternatives.

  • Reuters7 days ago

    UPDATE 5-Gunmen kill 7 in Kenya hotel compound attack claimed by Somali Islamists

    Gunmen blasted their way into a hotel and office complex in the Kenyan capital on Tuesday, killing at least seven people and sending workers diving under desks from an attack claimed by Somali Islamists al Shabaab. Police warned the "terror attack", which echoed a 2013 assault on a Nairobi shopping centre, may be ongoing, with assailants still inside the upscale 14 Riverside Drive complex.

  • Reuters7 days ago

    British shares up on China stimulus hopes, all eyes on Brexit deal vote

    By Shashwat Awasthi and Muvija M (Reuters) - Britain's FTSE 100 rose on Tuesday on hopes Beijing will take steps to stabilise a slowing economy, while mid-caps edged up in choppy trade as investors remained ...

  • Reuters7 days ago

    Germany's SAP says all staff safe after Nairobi attack

    German business software group SAP said all staff working at its office in Nairobi had been brought to safety after an attack by gunmen on a hotel and office complex in the Kenyan capital. "We have confirmation that all our staff have been accounted for," a company spokeswoman said in response to a Reuters inquiry.

  • Reuters9 days ago

    JAB expands management as Chairman Becht retires

    JAB Holding Co, the private owner of coffee and restaurant businesses including Keurig Dr Pepper (KDP.N) and Pret A Manger, will bring in three new executives as its chairman, Bart Becht, retires. Becht, a consumer industry veteran and former CEO of Reckitt Benckiser (RB.L) will retire this year, JAB, controlled by the billionaire Reimann family, said on Monday, without giving a date.

  • Reuters15 days ago

    Trade talks rally shortlived as Brexit blues knock FTSE

    The main index (.FTSE) fell 0.4 percent while a boost from consumer stocks helped the mid-cap index (.FTMC) notch a three-and-a-half-week high and close 1 percent higher. Although UK stocks opened higher, the FTSE 100 - which makes about 70 percent of its income abroad - erased those early gains, with tobacco and consumer staples, including AstraZeneca (AZN.L), Reckitt Benckiser (RB.L), Unilever (ULVR.L), the biggest drags, weighed down by a weaker dollar. British American Tobacco (BATS.L) and Imperial Brands (IMB.L) extended losses to shed 4.2 percent and 5 percent, respectively, after a Cowen downgrade in light of higher e-cigarette use among youngsters.

  • Reuters23 days ago

    FTSE 100 slightly lower in fitting farewell to dim 2018

    By Muvija M and Shashwat Awasthi (Reuters) - The UK blue-chip index ended its worst year since the 2008 financial crisis in the red, as a strong pound pulled down exporter shares, offsetting U.S. President ...

  • Reckitt Can Still Make it to the Glaxo-Pfizer Party
    Bloomberglast month

    Reckitt Can Still Make it to the Glaxo-Pfizer Party

    GlaxoSmithKline Plc and Pfizer Inc. said Wednesday they would combine their consumer healthcare businesses into a new joint venture. Both Reckitt and Glaxo had looked at Pfizer's consumer health unit, which makes Advil, earlier this year. Reckitt had good reason to turn it down.

  • Reuters2 months ago

    New Beiersdorf CEO poaches from rivals in management reshuffle

    Beiersdorf (BEIG.DE), the maker of Nivea skin creams, is shaking up its top management team when new chief executive Stefan De Loecker takes over on Jan. 1, poaching managers from rivals Procter & Gamble (PG.N) and Reckitt Benckiser (RB.L). Beiersdorf said Asim Naseer, P&G global marketing director for skin care, would take over as head of consumer brands from Jan. 1, replacing Ralph Gusko, who continues his responsibility for Asia Pacific for now but will leave by the end of 2019. Ramon Mirt, who headed Reckitt Benckiser's business in central and eastern Europe, will take charge of the Near East and Americas regions for Beiersdorf in March, the firm said.

  • New Beiersdorf CEO poaches from rivals in management reshuffle
    Reuters2 months ago

    New Beiersdorf CEO poaches from rivals in management reshuffle

    Beiersdorf (BEIG.DE), the maker of Nivea skin creams, is shaking up its top management team when new chief executive Stefan De Loecker takes over on Jan. 1, poaching managers from rivals Procter & Gamble (PG.N) and Reckitt Benckiser (RB.L). Beiersdorf said Asim Naseer, P&G global marketing director for skin care, would take over as head of consumer brands from Jan. 1, replacing Ralph Gusko, who continues his responsibility for Asia Pacific for now but will leave by the end of 2019. Ramon Mirt, who headed Reckitt Benckiser's business in central and eastern Europe, will take charge of the Near East and Americas regions for Beiersdorf in March, the firm said.

  • MS Global Franchise Fund's Top 5 Buys in 3rd Quarter
    GuruFocus.com2 months ago

    MS Global Franchise Fund's Top 5 Buys in 3rd Quarter

    Fund adds to two existing positions and introduces three new holdings

  • Reuters2 months ago

    Indivior backs FY view, warns of generic rival hit; shares fall

    The company stuck to its full-year forecast on Wednesday, but warned it could take a hit if the rival drug from Dr. Reddy's Laboratories Ltd (REDY.NS) comes to market this year. Indivior's shares nearly halved in value on Tuesday and sank to an all-time low of 104.95 pence after a preliminary injunction blocking Dr. Reddy's from selling the generic was lifted by a U.S. court. Indivior has been battling the introduction of a cheaper generic version of Suboxone, and has also faced distribution challenges with its new injectable opioid addiction drug, Sublocade.

  • Reuters3 months ago

    BP 'blowout' results keep FTSE afloat as Reckitt tumbles

    A strong update from BP helped the UK's top share index end a choppy session in the black on Tuesday, offsetting disappointing results from heavyweight Reckitt Benckiser and outperforming European equities. Heavyweight BP (BP.L) rose two percent after quarterly profits at the oil major reached a five-year high, boosted by stronger oil prices and as production rose thanks to new fields. The energy sector provided the biggest boost to the FTSE 100 but gains were curbed by a disappointing update from Reckitt Benckiser (RB.L).

  • Reuters3 months ago

    Infant formula growing pains hurt Reckitt Benckiser sales

    A manufacturing glitch at a Dutch factory producing baby milk hurt Reckitt Benckiser's third-quarter sales, the latest in a string of problems to hit the British consumer goods group, this time, in the formula business it bought last year for $17 billion. The setback comes as the maker of Durex condoms and Enfamil infant formula had begun to gather momentum after two years of disappointing results caused by a failed product launch, a cyber attack and a safety scandal in South Korea. Shares in Reckitt Benckiser were down 5.3 percent in London at 1326 GMT.

  • Reuters3 months ago

    Europe gives up gains as earnings disappointments from Lufthansa, BNP Paribas weigh

    European shares swung back into negative territory on Tuesday after a strong start, buckling under the weight of disappointing earnings updates as strains rippled through the airline, banking and construction sectors. The leading euro zone stocks index was down 0.4 percent by 0930 GMT, while Germany's DAX (.GDAXI) fell 0.6 percent and Britain's FTSE 100 (.FTSE) climbed 0.1 percent. U.S. stocks were hit on Monday by a report that Washington plans to impose tariffs on all Chinese imports if no progress is made in talks between presidents Donald Trump and Xi Jinping.